Despite significant challenges caused by COVID-19 disruptions, the pharmaceutical track-and-trace sector has made strides in three areas to help secure the global supply chain now and well into the future.

To safeguard drug supplies, pharmaceutical companies should go beyond simple regulatory compliance by tapping into the transformational and unrealized business value of track-and-trace packaging technology.

FDA is delaying enforcement of the upcoming product identifier requirement under the Drug Supply Chain Security Act, but should this delay alter your plans?This past June, FDA announced that the agency “does not intend to take action against...

Validation is a critical step in implementing serialization programs. Planning your validation approach early on can help you establish your solution objectives and work toward minimal production downtime and cost, explains Vito Pirrera, executive...

To help medical device manufacturers meet Unique Device Identification (UDI) rules as well as satisfy other marking needs, RTP Company has introduced laser-markable thermoplastic compounds. The materials can be used for packaging as well as for...

Late 2016 was a busy season for Brazil, as the end of the year saw several developments in Brazil’s serialization program for medicines, Peter Schmitt, Managing Director & Co-Founder of Montesino Associates, tells PMP News.Schmitt will be sharing...

With about one year to go before U.S. deadlines begin phasing in, serialization continues to present challenges for pharmaceutical companies. “Time’s running out,” says Jim Cummings, vice president, Americas, for Adents. He spoke with PMP News at...